In this episode, co-host Andreas Seas interviews Jon Nelson who shares his experience with deep brain stimulation for treatment-resistant depression. Listen as he shares about the hope this treatment approach gave him and how DBS has transformed his life. This treatment remains investigational, but with the studies underway that can help patients like Jon, we can start to understand the profound impact it can have.
All content for ASSFN Podcast is the property of ASSFN and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, co-host Andreas Seas interviews Jon Nelson who shares his experience with deep brain stimulation for treatment-resistant depression. Listen as he shares about the hope this treatment approach gave him and how DBS has transformed his life. This treatment remains investigational, but with the studies underway that can help patients like Jon, we can start to understand the profound impact it can have.
Transition to Practice with Dr. Sharona Ben-Haim and Dr. Christopher Conner
ASSFN Podcast
34 minutes
7 months ago
Transition to Practice with Dr. Sharona Ben-Haim and Dr. Christopher Conner
In this episode, co-hosts Dr. Danika Paulo, Dr. Harsh Shah and Andreas Seas talk with featured guests, Dr. Sharona Ben-Haim and Dr. Christopher Conner about transitioning from being a neurosurgical trainee to starting practice. Dr. Ben-Haim is an academic functional neurosurgeon at the University of California, San Diego and Surgical Director of Epilepsy as well as a board member of the ASSFN. Dr. Conner is a functional neurosurgeon with a privademic practice affiliated with UConn Health. Bot...
ASSFN Podcast
In this episode, co-host Andreas Seas interviews Jon Nelson who shares his experience with deep brain stimulation for treatment-resistant depression. Listen as he shares about the hope this treatment approach gave him and how DBS has transformed his life. This treatment remains investigational, but with the studies underway that can help patients like Jon, we can start to understand the profound impact it can have.
